These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 2887440
21. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat. Hekmatpanah CR, McKenna DJ, Peroutka SJ. Neurosci Lett; 1989 Sep 25; 104(1-2):178-82. PubMed ID: 2573011 [Abstract] [Full Text] [Related]
22. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI, Green AR. Br J Pharmacol; 1994 Jan 25; 111(1):131-6. PubMed ID: 7516800 [Abstract] [Full Text] [Related]
28. Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). Sharkey J, McBean DE, Kelly PA. Psychopharmacology (Berl); 1991 Jan 25; 105(1):113-8. PubMed ID: 1684057 [Abstract] [Full Text] [Related]
29. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Battaglia G, Sharkey J, Kuhar MJ, de Souza EB. Synapse; 1991 Aug 25; 8(4):249-60. PubMed ID: 1681594 [Abstract] [Full Text] [Related]
30. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW. Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597 [Abstract] [Full Text] [Related]
31. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. Callaghan PD, Farrand K, Salem A, Hughes P, Daws LC, Irvine RJ. Eur J Pharmacol; 2006 Sep 28; 546(1-3):74-81. PubMed ID: 16925993 [Abstract] [Full Text] [Related]
32. Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices. Fitzgerald JL, Reid JJ. Eur J Pharmacol; 1990 Nov 27; 191(2):217-20. PubMed ID: 1982265 [Abstract] [Full Text] [Related]
37. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. Nash JF, Meltzer HY, Gudelsky GA. J Pharmacol Exp Ther; 1988 Jun 27; 245(3):873-9. PubMed ID: 2898523 [Abstract] [Full Text] [Related]
38. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW. J Pharmacol Exp Ther; 1988 Mar 27; 244(3):977-82. PubMed ID: 2472482 [Abstract] [Full Text] [Related]
39. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy"). Colado MI, Granados R, O'Shea E, Esteban B, Green AR. Pharmacol Toxicol; 1999 Jun 27; 84(6):261-6. PubMed ID: 10401727 [Abstract] [Full Text] [Related]
40. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Paris JM, Cunningham KA. Brain Res Bull; 1992 Jan 27; 28(1):115-9. PubMed ID: 1347247 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]